Form 8-K - Current report:
SEC Accession No. 0001104659-25-096966
Filing Date
2025-10-06
Accepted
2025-10-06 09:08:18
Documents
14
Period of Report
2025-10-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2528058d1_8k.htm   iXBRL 8-K 24824
2 EXHIBIT 99.1 tm2528058d1_ex99-1.htm EX-99.1 20110
6 GRAPHIC tm2528058d1_ex99-1img001.jpg GRAPHIC 3296
  Complete submission text file 0001104659-25-096966.txt   219725

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lptx-20251006.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20251006_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20251006_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2528058d1_8k_htm.xml XML 3686
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 251375809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)